Literature DB >> 26175248

Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus.

Michael C d'Emden1, Jonathan E Shaw2, Graham R Jones3, N Wah Cheung4.   

Abstract

Glycated haemoglobin (HbA1c) assessment for the diagnosis of diabetes mellitus overcomes many practical problems associated with traditional blood glucose measurements. However, the test is not without limitations of which the medical practitioner needs to be aware. The possibility of an individual having a medical condition that interferes with the test should always be considered, even though these conditions are rare in most Australian communities. Appropriately used, HbA1c assessment should provide a cost-effective, efficient and simple tool for the early diagnosis of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26175248     DOI: 10.5694/mja15.00041

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  12 in total

1.  ADNCD: a compendious database on anti-diabetic natural compounds focusing on mechanism of action.

Authors:  Aisha Khatoon; Iliyas Rashid; Sibhghatulla Shaikh; Syed Mohd Danish Rizvi; Shazi Shakil; Neelam Pathak; Snober S Mir; Khurshid Ahmad; Talib Hussain; Prachi Srivastava
Journal:  3 Biotech       Date:  2018-08-06       Impact factor: 2.406

2.  Ethnic variation in acute cerebrovascular disease: Analysis from the Qatar stroke registry.

Authors:  Naveed Akhtar; Abdul Salam; Saadat Kamran; Paula Bourke; Sujatha Joseph; Mark Santos; Rabia Khan; Furqan Irfan; Dirk Deleu; Rayaz A Malik; Ashfaq Shuaib
Journal:  Eur Stroke J       Date:  2016-08-10

Review 3.  Diabetes mellitus in elderly.

Authors:  Farida Chentli; Said Azzoug; Souad Mahgoun
Journal:  Indian J Endocrinol Metab       Date:  2015 Nov-Dec

Review 4.  Services aimed at achieving desirable clinical outcomes in patients with chronic kidney disease and diabetes mellitus: A narrative review.

Authors:  Fergus William Gardiner; Ezekiel Uba Nwose; Phillip Taderera Bwititi; Judith Crockett; Lexin Wang
Journal:  SAGE Open Med       Date:  2017-11-17

5.  Better Indigenous Risk stratification for Cardiac Health study (BIRCH) protocol: rationale and design of a cross-sectional and prospective cohort study to identify novel cardiovascular risk indicators in Aboriginal Australian and Torres Strait Islander adults.

Authors:  Marc G W Rémond; Simon Stewart; Melinda J Carrington; Thomas H Marwick; Bronwyn A Kingwell; Peter Meikle; Darren O'Brien; Nathaniel S Marshall; Graeme P Maguire
Journal:  BMC Cardiovasc Disord       Date:  2017-08-23       Impact factor: 2.298

6.  AMPKα, hs-CRP and FcγR in diabetic nephropathy and drug intervention.

Authors:  Ping Sun; Lei Lu; Jun Chen; Xiao Dan Liu; Qing Zhang; Xu Wang
Journal:  Exp Ther Med       Date:  2018-04-04       Impact factor: 2.447

7.  Bacterial distribution, changes of drug susceptibility and clinical characteristics in patients with diabetic foot infection.

Authors:  Ling Liu; Zhihui Li; Xinxin Liu; Shan Guo; Limin Guo; Xuelian Liu
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

8.  Risk-adjustment of diabetes health outcomes improves the accuracy of performance benchmarking.

Authors:  Eleanor Danek; Arul Earnest; Natalie Wischer; Sofianos Andrikopoulos; Anthony Pease; Natalie Nanayakkara; Sophia Zoungas
Journal:  Sci Rep       Date:  2018-07-06       Impact factor: 4.379

9.  Undiagnosed hypertension and diabetes among the elderly in Amirkola, North of Iran.

Authors:  Seyed Reza Seyed Reza; Mohammadali Bayani; Ali Zabihi; Moghaddeseh Shakerian; Tara Habibian; Ali Bijani
Journal:  Caspian J Intern Med       Date:  2019

10.  Does a hospital diabetes inpatient service reduce blood glucose and HbA1c levels? A prospective cohort study.

Authors:  Fergus William Gardiner; Ezekiel Uba Nwose; Phillip Taderera Bwititi; Judith Crockett; Lexin Wang
Journal:  Ann Med Surg (Lond)       Date:  2017-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.